A First in Human Study in Healthy Volunteers and in Participants With Frontotemporal Dementia With Granulin (GRN) Mutation

NCT03636204 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

64

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy
Frontotemporal Dementia

Interventions

BIOLOGICAL: AL001
OTHER: Placebo

Sponsor

Alector Inc.